GSE207410 GSE207411 ARID1A knockdown 7 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE207410_GSE207411_ARID1A knockdown_7_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE207410_GSE207411_ARID1A knockdown_7_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE207410_GSE207411_ARID1A knockdown_7_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE207410_GSE207411_ARID1A knockdown_7_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

H4 clustered histone 15

Gene

H2B clustered histone 8

Gene

H3 clustered histone 7

Gene

H2A clustered histone 11

Gene

non-coding RNA activated by DNA damage

Gene

H2A clustered histone 4

Gene

p53 upregulated regulator of p53 levels

Gene

lung cancer associated transcript 1

Gene

H3 clustered histone 10

Gene

long intergenic non-protein coding RNA 472

  • Gene

    H4 clustered histone 15


  • Gene

    H2B clustered histone 8


  • Gene

    H3 clustered histone 7


  • Gene

    H2A clustered histone 11


  • Gene

    non-coding RNA activated by DNA damage


  • Gene

    H2A clustered histone 4


  • Gene

    p53 upregulated regulator of p53 levels


  • Gene

    lung cancer associated transcript 1


  • Gene

    H3 clustered histone 10


  • Gene

    long intergenic non-protein coding RNA 472

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.